• SENSEX 79,310.01
    2,008.61 (+2.60%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,900.00 1,878.00(%)
  • ICICI Bank
    1,501.45 1,479.90(%)
  • ITC
    277.30 252.80(%)
  • Reliance Industries
    1,325.00 1,611.20(%)
  • M & M
    3,143.95 3,840.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Tonbo Imaging
    1,533.65 1,343.80(%)
  • Tube Investments
    2,310.10 3,335.00(%)
  • TCS
    2,521.00 3,336.70(%)
  • Axis Bank
    1,286.40 1,418.30(%)
  • Aurobindo Pharma
    1,796.95 1,739.95(%)
  • HDFC Life Insur.
    546.20 788.50(%)
  • SBI
    1,009.65 1,234.80(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • P I Industries
    1,749.45 2,006.00(%)
  • Jio Platforms
    1,410.05 1,356.40(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Bajaj Finance
    1,073.70 1,177.60(%)
  • Bharti Airtel
    2,048.00 1,726.05(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syncom Formulations (India) Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3544.0
  • ISIN : INE312C01025
20.56 1 (7.81%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    18.95

  • Today’s High

    20.69

  • Open

    19.07

  • Perv Close

    19.07

  • 52W Low

    10.21

  • 52W High

    27.49

Key Indicators

  • P/E(TTM)

    22.84

  • Mar.Cap (₹Cr.)

    1,932.64

  • Div & Yield %

    0.49

  • Book Value(₹)

    4.39

  • Debt-Equity Ratio

    7.81

  • AGM Date

    04-Nov-2026

  • EPS

    0.90

  • P/E Ratio

    22.84

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    1,932.64

  • RONW (%)

    9.30

  • ROCE (%)

    10.91

Score Board

  • Equity (₹ in Cr.)

    94.00

  • BV (₹)

    4.40

  • Sales( ₹ in Cr.)

    486.57

  • NP (in Cr.)

    66.20

  • NP Var(%)

    37.0

  • Div%

    10.0

  • CPS (₹)

    0.80

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    1,932.64

  • 52 Week High

    27.49

  • 52 Week Low

    10.21

  • Price BSE

    21.0

  • Price NSE

    21.00

  • Market Capital( in Cr.)

    1,932.64

  • P/C Ratio

    27.10

  • P/E Ratio

    29.80

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 486.57 462.85 258.36 224.64 219.66 244.81
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 486.57 462.85 258.36 224.64 219.66 244.81
Other Income 31.00 17.20 13.10 14.62 12.02 7.17
Stock Adjustments 3.90 10.62 2.18 -0.05 -3.32 4.05
Total Income 521.47 490.67 273.64 239.21 228.36 256.03
EXPENDITURE :            
Raw Materials 287.64 317.51 157.74 142.07 137.23 165.51
Power and Fuel Cost 6.19 5.62 6.13 5.31 4.38 3.84
Employee Cost 65.08 50.56 33.57 24.44 20.73 18.24
Other Manufacturing Expenses 4.16 2.88 2.39 3.19 2.26 2.09
Selling and Administration Expenses 44.57 39.22 29.62 27.29 29.71 19.79
Miscellaneous Expenses 5.67 4.00 3.03 2.41 2.00 1.34
Employee Benefit Expenses 65.08 50.56 33.57 24.44 20.73 18.24
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 413.31 419.79 232.47 204.71 196.32 210.81
Operating Profit 108.17 70.88 41.18 34.51 32.05 45.22
Interest 1.11 1.03 4.70 3.40 1.93 0.48
Gross Profit 107.06 69.85 36.48 31.11 30.12 44.74
Depreciation 6.53 5.19 4.72 4.54 3.95 4.03
Profit Before Tax 100.53 64.66 31.76 26.57 26.17 40.71
Current Tax 22.70 14.45 7.58 6.65 6.25 11.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.81 1.33 0.55 -0.15 0.14 0.23
Reported Net Profit 76.01 48.87 23.62 20.07 19.79 29.17
Extraordinary Items 9.80 0.52 0.55 0.14 0.03 0.10
Adjusted Net Profit 66.21 48.35 23.07 19.93 19.76 29.07
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 151.86 102.99 79.36 62.11 42.32 13.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 2.82 0.00 0.00
P & L Balance carried down 227.87 151.86 102.99 79.36 62.11 42.32
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 0.00 0.00 0.00 3.00 0.00
Dividend Per Share(Rs) 0.10 0.00 0.00 0.00 0.03 0.00
Earnings Per Share-Unit Curr 0.81 0.52 0.25 0.21 0.23 0.37
Earnings Per Share(Adj)-Unit Curr 0.81 0.52 0.25 0.21 0.23 0.37
Book Value 4.39 3.62 3.05 2.72 2.52 2.25
Book Value(Adj)-Unit Curr 4.39 3.62 3.05 2.72 2.52 2.25

Shareholding Pattern

  • Promoter Group

    50.57%

  • Public Share Holding

    49.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 83,061,125 8.84 83,061,125 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 392,286,474 41.73 392,286,474 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 475,347,599 50.57 475,347,599 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 7,000 0.00 7,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 4,500 0.00 4,500 1
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 20,910,817 2.22 20,910,817 22
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 18,877 0.00 18,877 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,941,194 2.23 20,941,194 26
2] Non Institution
Bodies Corporate 13,013,868 1.38 13,011,368 238
Clearing Members 1,011,586 0.11 1,011,586 32
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 16,674,331 1.77 16,571,831 2,117
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 11,033,316 1.17 11,033,316 1,861
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 60,580,883 6.44 60,580,883 141
Individuals holding nominal share capital up to Rs. 1 lakh 337,698,090 35.93 335,388,910 414,003
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,320,331 0.25 2,320,331 1
Sub Total 443,711,207 47.20 441,297,027 418,426
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 940,000,000 100.00 937,585,820 418,465

Company Background

Syncom Formulations (India) LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Syncom Formulations (India) Ltd
  • BSE Code : 3544.0
  • ISIN : INE312C01025

  • Incorporation Year

    1988

  • Registered Office

    7 Niraj Indl Estate Andheri(E)
    Off Mahakali Caves Rd, Mumbai,
    Maharashtra-400093

  • Telephone

    91-22-30887744

  • FAX

    91-22-30887755

  • Chairman

    ANKIT KEDARMAL BANKDA

  • Managing Director

    Rahul Vijay Bankda

  • Company Secretary

    Vaishali Agrawal

  • Auditor

    Sanjay Mehta & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Syncom Formulations (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syncom Formul. 20.56 517.54 486.57 22.84 26.42
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77